.AstraZeneca managers claim they are "certainly not troubled" that the failing of tozorakimab in a p...
.Accept to this week's Chutes & Ladders, our roundup of substantial management hirings, shootings...
.After showing plannings to hit the united state social markets lower than a month back, Zenas Bioph...
.Psyence Biomedical is paying $500,000 in shares to get fellow psilocybin-based biotech Clairvoyant ...
.Five months after signing off on Power Rehabs' Pivya as the first brand-new therapy for straightfor...
.Eli Lilly has vaulted right into an AI-enabled drug invention package, partnering with RNA expert H...
.Lykos CEO and founder Amy Emerson is walking out, with main working policeman Michael Mullette taki...
.Novartis levels a brand new frontier in its partnership along with Voyager Rehabs, paying for $15 m...
.On the heels of an FDA being rejected for its own primary rival Novo Nordisk, Eli Lilly is actually...
.Simply a few months after dosing the first individual in a phase 2 trial for freshly diagnosed glio...